Soliman, Ahmed M

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The …

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The …

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The …

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The …

Provide enhanced digital features for this article This Figshare page contains a Summary Slide. If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact adi…

We evaluated elagolix and leuprolide from the patient’s perspective for the treatment of endometriosis-related pain. Preference weights from a published discrete choice experiment were used to evaluate preferences for treatment profiles sim…

We evaluated elagolix and leuprolide from the patient’s perspective for the treatment of endometriosis-related pain. Preference weights from a published discrete choice experiment were used to evaluate preferences for treatment profiles sim…

Supplemental material, sj-pdf-1-whe-10.1177_1745506520965898 for The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States by Stephani…

Supplemental material, sj-pdf-1-whe-10.1177_1745506520965898 for The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States by Stephani…

Objectives:Evaluate all-cause and endometriosis-related health care resource utilization and costs among newly diagnosed endometriosis patients with high-risk versus low-risk opioid use or patients with chronic versus non-chronic opioid use…

Objectives:Evaluate all-cause and endometriosis-related health care resource utilization and costs among newly diagnosed endometriosis patients with high-risk versus low-risk opioid use or patients with chronic versus non-chronic opioid use…

Introduction:We aimed to characterize the treatment patterns of women with a self-reported diagnosis of endometriosis in Canada.Methods:Between December 2018 and January 2019 an online cross-sectional survey was administered to women aged 1…

Introduction:We aimed to characterize the treatment patterns of women with a self-reported diagnosis of endometriosis in Canada.Methods:Between December 2018 and January 2019 an online cross-sectional survey was administered to women aged 1…

Supplemental material, UK_ExclusiveLicence_JEPPD_Singh for Treatment patterns of women with endometriosis in Canada by Sukhbir Singh, Ahmed M Soliman, Yasmine Rahal, Catherine Robert, Isabelle Defoy, Paul Nisbet and Nicholas Leyland in Jour…

Supplemental material, UK_ExclusiveLicence_JEPPD_Singh for Treatment patterns of women with endometriosis in Canada by Sukhbir Singh, Ahmed M Soliman, Yasmine Rahal, Catherine Robert, Isabelle Defoy, Paul Nisbet and Nicholas Leyland in Jour…

Supplemental material, UK_ExclusiveLicence_JEPPD_Withycombe for Treatment patterns of women with endometriosis in Canada by Sukhbir Singh, Ahmed M Soliman, Yasmine Rahal, Catherine Robert, Isabelle Defoy, Paul Nisbet and Nicholas Leyland in…

Supplemental material, UK_ExclusiveLicence_JEPPD_Withycombe for Treatment patterns of women with endometriosis in Canada by Sukhbir Singh, Ahmed M Soliman, Yasmine Rahal, Catherine Robert, Isabelle Defoy, Paul Nisbet and Nicholas Leyland in…

Objectives:The objective was to evaluate the effects of elagolix on dyspareunia in women with endometriosis-associated pain.Methods:Data were pooled from two similar, randomized, double-blind, placebo-controlled, 6-month phase 3 studies (El…

Objectives:The objective was to evaluate the effects of elagolix on dyspareunia in women with endometriosis-associated pain.Methods:Data were pooled from two similar, randomized, double-blind, placebo-controlled, 6-month phase 3 studies (El…

Provide enhanced digital features for this article This Figshare page contains a Summary Slide. If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact adi…

Article full text The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. In the meantime,…

Supplemental material, Leyland_EMph3_Dysp_appendix_revision_1July2019 for Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain by Nicholas Leyland, Hugh S Taylor,…

Supplemental material, Leyland_EMph3_Dysp_appendix_revision_1July2019 for Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain by Nicholas Leyland, Hugh S Taylor,…

Article full text The full text of this article can be found here. Provide enhanced digital features for this article If you are an author of this publication and would like to provide additional enhanced digital features for your article…

Article full text The full text of this article can be found here. Provide enhanced digital features for this article If you are an author of this publication and would like to provide additional enhanced digital features for your article…